Примери за използване на Busulfan fresenius на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Quantity of Busulfan Fresenius Kabi.
Busulfan Fresenius Kabi may interact with other medicines.
How to use Busulfan Fresenius Kabi.
Busulfan Fresenius Kabi must be diluted prior to administration.
How to store Busulfan Fresenius Kabi.
Busulfan Fresenius Kabi destroys the original bone marrow before the transplant.
Other information about Busulfan Fresenius Kabi.
How is Busulfan Fresenius Kabi used?
Medicines before you receive Busulfan Fresenius Kabi.
How has Busulfan Fresenius Kabi been studied?
Read this guide prior to the preparation and administration of Busulfan Fresenius Kabi.
A ml of Busulfan Fresenius Kabi to be diluted.
Women must stop breast-feeding before starting their treatment with Busulfan Fresenius Kabi.
Why is Busulfan Fresenius Kabi approved?
A risk management plan has been developed to ensure that Busulfan Fresenius Kabi is used as safely as possible.
What Busulfan Fresenius Kabi is and what it is used for.
Women must not be pregnant during treatment with Busulfan Fresenius Kabi and up to 6 months after treatment.
Diluted Busulfan Fresenius Kabi is a clear colourless solution.
When used in combination with cyclophosphamide ormelphalan the recommended dose of Busulfan Fresenius Kabi in adults is 0.8 mg per kilogram body weight.
Busulfan Fresenius Kabi is a medicine that contains the active substance busulfan. .
The Committee recommended that Busulfan Fresenius Kabi be approved for use in the EU.
Busulfan Fresenius Kabi is a potent cytotoxic medicine that results in profound decrease of blood cells.
In adult patients who are eligible for a‘reduced-intensity' conditioning regimen, Busulfan Fresenius Kabi is given right after treatment with another medicine, fludarabine.
In adults Busulfan Fresenius Kabi is used in combination with cyclophosphamide or fludarabine.
The Agency's Committee for Medicinal Products for Human Use(CHMP)concluded that, in accordance with EU requirements, Busulfan Fresenius Kabi has been shown to be comparable to Busilvex.
The amount of Busulfan Fresenius Kabi and diluent to be administered would be calculated as follows.
Busulfan Fresenius Kabi must be prepared by a healthcare professional using sterile transfer techniques.
The active substance in Busulfan Fresenius Kabi, busulfan, belongs to a group of medicines called‘alkylating agents'.
Busulfan Fresenius Kabi is supplied in colourless glass vials, each vial containing 60 mg of busulfan. .
For more information about treatment with Busulfan Fresenius Kabi, read the package leaflet(also part of the EPAR) or contact your doctor or pharmacist.